Chatain, N
Perera, R C
Rossetti, G
Rossa, J
Carloni, P
Schemionek, M
Haferlach, T
Brümmendorf, T H
Schnittger, S
Koschmieder, S
Article History
First Online: 27 May 2015
Competing interests
: SK has received honoraria for consultancy from Novartis, Pfizer, Brystol-Meyers Squibb, and Ariad. TH and SS have equity ownership of MLL. THB has received honoraria for consultancy from Novartis, Pfizer, Brystol-Meyers Squibb. The remaining authors declare no conflict of interest.